ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 19 filers reported holding ATYR PHARMA INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,000 | 0.0% | 3,410 | -12.2% | 0.00% | – |
| Q4 2018 | $2,000 | -33.3% | 3,882 | +0.1% | 0.00% | – |
| Q3 2018 | $3,000 | -81.2% | 3,877 | -78.5% | 0.00% | – |
| Q2 2018 | $16,000 | -66.7% | 18,003 | -0.6% | 0.00% | – |
| Q1 2018 | $48,000 | -48.9% | 18,103 | -32.6% | 0.00% | – |
| Q4 2017 | $94,000 | -37.3% | 26,852 | -9.3% | 0.00% | – |
| Q3 2017 | $150,000 | +47.1% | 29,620 | -0.6% | 0.00% | – |
| Q2 2017 | $102,000 | -42.7% | 29,797 | -41.1% | 0.00% | – |
| Q1 2017 | $178,000 | +270.8% | 50,616 | +124.4% | 0.00% | – |
| Q4 2016 | $48,000 | +500.0% | 22,560 | +744.0% | 0.00% | – |
| Q3 2016 | $8,000 | -42.9% | 2,673 | -44.8% | 0.00% | – |
| Q2 2016 | $14,000 | +27.3% | 4,842 | +73.9% | 0.00% | – |
| Q1 2016 | $11,000 | -76.6% | 2,785 | -41.0% | 0.00% | – |
| Q4 2015 | $47,000 | +123.8% | 4,723 | +124.9% | 0.00% | – |
| Q3 2015 | $21,000 | -47.5% | 2,100 | -3.2% | 0.00% | – |
| Q2 2015 | $40,000 | – | 2,170 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,827,992 | $3,930,000 | 4.66% |
| EcoR1 Capital, LLC | 976,986 | $2,101,000 | 0.67% |
| TANG CAPITAL MANAGEMENT LLC | 279,425 | $601,000 | 0.32% |
| Rock Springs Capital Management LP | 475,000 | $1,021,000 | 0.07% |
| Quotient Investors, LLC | 22,200 | $48,000 | 0.03% |
| Alyeska Investment Group, L.P. | 1,072,108 | $2,305,000 | 0.02% |
| TIVERTON ASSET MANAGEMENT LLC | 95,318 | $205,000 | 0.01% |
| RIVERHEAD CAPITAL MANAGEMENT LLC | 79,677 | $171,000 | 0.01% |
| Acrospire Investment Management LLC | 12,683 | $27,000 | 0.01% |
| Glen Harbor Capital Management LLC | 179,724 | $386,000 | 0.01% |